Normal fetal brain growth charts from routine MRI scans

Courbes Normatives De Volumes Cérébraux Issues D'IRM Fœtales Multicentriques

Observational Assistance Publique Hopitaux De Marseille · NCT06081036

This project will create MRI-based charts of normal fetal brain volume using past routine scans from four French hospitals to help doctors interpret fetal brain images.

Quick facts

Study typeObservational
Enrollment1423 (estimated)
Ages20 Weeks to 37 Weeks
SexAll
SponsorAssistance Publique Hopitaux De Marseille Academic / other
Locations1 site (Marseille)
Trial IDNCT06081036 on ClinicalTrials.gov

What this trial studies

Researchers will collect routine fetal brain MRIs acquired more than three years ago at four French centers (Marseille, Nice, Montpellier, Paris) and centralize scans that show no abnormalities. Families of included children will be contacted to provide postnatal development information via questionnaires. Images will be processed with automated methods developed by the Marseille laboratory to measure brain tissue volumes and cortical metrics. From these measurements the team will construct normative growth curves of fetal brain volume and cortical thickness to support prenatal diagnosis and prognosis.

Who should consider this trial

Good fit: Ideal candidates are children who had a fetal brain MRI more than three years ago at one of the four partner centers and whose scans showed no abnormalities, with families willing to be contacted for follow-up questionnaires.

Not a fit: Children with corpus callosum malformations, genetic or chromosomal syndromes, syndromic extracerebral malformations, intrauterine growth restriction, confirmed maternal-fetal infection, multiple pregnancy, maternal diabetes treated during pregnancy, maternal antiepileptic drug exposure, significant alcohol or drug use, arachnoid cysts with mass effect, or whose parents object are excluded and unlikely to benefit from the normative curves.

Why it matters

Potential benefit: If successful, the resulting normative curves could help clinicians distinguish normal from abnormal fetal brain development and improve prenatal counseling and prognostic accuracy.

How similar studies have performed: Prior single-center research has shown that antenatal MRI measures can predict postnatal development, but multicenter normative volumetric curves derived from routine clinical fetal MRI remain largely novel.

Eligibility criteria

Show full inclusion / exclusion criteria
Inclusion Criteria:

Child who has had, more than 3 years ago, a cerebral MRI during the fetal period in one of the 4 partner centers

Exclusion Criteria:

* Child suffering from a commissural malformation (anomaly of the corpus callosum)
* Child with a genetic syndrome and/or chromosomal abnormality and/or deleterious mutation
* Child with syndromic extra-cerebral malformations (including cardiac malformations)
* Child with intrauterine growth restriction reported in the obstetrical record
* Child with maternal-fetal infection (TORCH, parvovirus or other) confirmed by amniotic fluid test or neonatal urine test
* Multiple pregnancy
* Mother with diabetes treated during pregnancy (including gestational diabetes, if treated)
* Mother with antiepileptic medication during pregnancy
* Alcohol or drug use
* Presence of a sustentorial arachnoid cyst
* Presence of an arachnoid cyst with mass effect
* Objection from parental authority holders to participate in the study

Where this trial is running

Marseille

Study contacts

How to participate

  1. Review the eligibility criteria above with your treating physician.
  2. Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
  3. Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions Cortical Development MalformationMultiparametric Magnetic Resonnance ImagingBrain Cortical ThicknessPrenatal DiagnosisFetal Development
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.